Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GCT Selects CRO Starter Kit™ PSA Platform by Flex Databases

Published: Thursday, February 13, 2014
Last Updated: Thursday, February 13, 2014
Bookmark and Share
CRO Starter Kit™ provide increased efficiency and speed in running clinical research projects.

Flex Databases has announced that Global Clinical Trials, LLC (GCT) has selected Flex CRO Starter Kit™ as its business automation platform.

GCT is a regional Contract Research Organization (CRO), established in 2001 and headquartered in Princeton, NJ with full-service clinical operations in Russia and Eastern Europe.

"From the very foundation of the company GCT had a clear growth strategy", says Dr. Eugene Selivra, CEO of GCT. "We developed organically, step by step, basing our growth on the experience and knowledge of the management team and efficient business processes. But we always knew a time would come when we would need a software platform to help us handle the increased complexity, size and number of projects. We explored the market in search of a system that would become a core application, driving all of our day-to-day activities. The CRO Starter Kit™ platform became a perfect match for our needs. It has vital tools for a CRO today, such as budget management, eTMF, a Learning Management System, timesheets and more. But above all, CRO Starter Kit™ is a unique platform where ground level operational activities are seamlessly linked to project management, providing increased efficiency and speed in running clinical research projects."

"CRO Starter Kit™ is a platform which brings the company together, creating an environment where every action is interconnected with others", says Timur Galimov, Technical Director of Flex Databases. "Such a system becomes self-reinforcing and is much easier to adopt, because it touches a user from multiple angles. One of the big reasons why CTMS implementations fail is because they affect a limited number of users and become just another database, not connected to anything else and not affecting anything else. The experience and industry knowledge of GCT allowed them to avoid this pitfall by selecting Flex CRO Starter Kit™."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Flex Databases Launches New Web Site
New website cements the company's unique positioning as a PSA company.
Tuesday, March 25, 2014
Scientific News
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
Study to Assess Shorter-Duration Antibiotics in Children
Physicians plan a clinical trial to evaluate whether short course anti-biotics are effective at treating CAP in children.
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
Cancer Gene Predicts Treatment Response in Leukaemia
Study indicates the patients suffering from a lethal for of acute myeloid leukemia may live longer when receiving milder chemotherapy drugs.
Injectable Biologic Therapy Reduces Triglycerides
Study finds first-of-its-kind therapy promising for patients with high triglycerides, cholesterol.
Testing Zika Vaccine in Humans Begins
The first of five planned clinical trials to test ZPIV vaccine in humans has begun.
Combination Therapy Improved Chemoresistance in Ovarian Cancer
The study demonstrates how an existing class of targeted therapies could be used to potentiate the tumor suppression induced by cisplatin.
Gene Therapy for Blistering Skin Disease Shows Promise
Grafting genetically altered skin onto patients’ chronic wounds marks the first time skin-based gene therapy has been demonstrated to be safe and effective in humans.
Alzheimer’s Treatment Moves a Step Closer
Merck scientists have reported the discovery of verubecestat, a structurally unique, orally bioavailable small molecule that has been shown to target the most visible sign of the disease in the brain.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!